Patient, Recruitment

Incorporating Patient Voice to Improve Colitis Recruitment

Home
Research
Incorporating Patient Voice to Improve Colitis Recruitment

The Issues

One major function of platelets is to contribute to hemostasis: the process of stopping bleeding at the site of interrupted endothelium. They gather at the site and unless the interruption is physically too large, they plug the hole. First, platelets attach to substances outside the interrupted endothelium: adhesion. Second, they change shape, turn on receptors and secrete chemical messengers: activation. Platelets also participate in both innate and adaptive intravascular immune responses.

Thus, platelets transfusions are needed to treat “thrombocytopenia” which is a decrease in platelet concentration that is induced by a large number of diseases, many with a rising incidence due to population
chemlabs-15

The Approach

Today, due to the very low proportion of platelets in the blood and to the complexity of this long and multi steps centrifuge-based manufacturing process, Blood Banks world wide struggle to produce Platelets Concentrates with affordable pricing complying with high level regulatory mandatories. Indeed, Accoustophoresis allows a much softer processing (6 times below shear stress platelets’ activation threshold) than centrifuge methods, and thus to achieve a more efficient sorting and a expected better quality and preservation.

Thus, platelets transfusions are needed to treat “thrombocytopenia” which is a decrease in platelet concentration that is induced by a large number of diseases, many with a rising incidence due to population ageing, such as autoimmune diseases, hematologic malignancies, bone marrow suppression, side effects of heparin based treatment, haemophiliac patients, sickle cell disease, thalassemia, traumas and injuries. In most of countries, over 80% of platelets extraction are proceed by Blood Bank from Whole Blood donations.

The Benefits

Pancreas is a key vital organ whose dysfunction, linked to various pathologies, leads to physiological disorders responsible for chronic diseases that severely degrade the quality and life expectancy of patients. Some of these pathologies would require the use of organ transplants. However, since the proportion of rejections from pancreatic transplants is high (more than 45%), the lethal risks of such procedures are too high and organ transplantation is carried out only as a last resort.
Which Plan Is Right For Me?
Organic acids are metabolic intermediates produced in pathways of central energy production, detoxification, neurotransmitter breakdown, and intestinal microbial activity. Accumulation of specific organic acids in urine often signals a metabolic inhibition or block. This abnormality may be due to a nutrient deficiency.
Do I have to commit to a contract?
Organic acids are metabolic intermediates produced in pathways of central energy production, detoxification, neurotransmitter breakdown, and intestinal microbial activity. Accumulation of specific organic acids in urine often signals a metabolic inhibition or block. This abnormality may be due to a nutrient deficiency.
What Payment Methods Are Available?
Organic acids are metabolic intermediates produced in pathways of central energy production, detoxification, neurotransmitter breakdown, and intestinal microbial activity. Accumulation of specific organic acids in urine often signals a metabolic inhibition or block. This abnormality may be due to a nutrient deficiency.

test

Download

Kindly fill in your details. All fields mandatory.

    Download

    Kindly fill in your details. All fields mandatory.

      Raajesh Dhuria

      “To serve people with the highest quality healthcare solutions, and to do so through a brand they can always rely on for a healthier, happier lifestyle; because I believe there is no happiness without good health.” This is the simple, yet extraordinary vision of Mr Raajesh Dhuria, MD and CEO, a pharmaceutical leader with over three decades of experience not only in scaling up existing businesses in Multinational & Indian healthcare organisations but also creating new profitable ventures. A keen eye for identifying latest trends and driving teams with passion to create profitable brands and business is what distinguishes him from his peers. Having begun his career in the late 1980s, with Johnson & Johnson, Mr Dhuria up skilled himself quickly rose through his career to become a Sales Head in companies like Morepen labs & Cadila Pharmaceuticals in about a decade and a half. For many this would have been a big rise from a Medical representative to a sales head, but the hunger for doing things differently pushed him to do what very few people could achieve at that time- launch a pharmaceutical company. In 2003, Mr Dhuria launched Kinedex Healthcare Pvt. Ltd. He was responsible for the tremendous rise and success of the company over 15 years, including the popularity of the highly recommended brand for arthritis, Rosiflex. In 2019, the company was acquired by Eris pharmaceuticals, following which Mr Dhuria helped establish Novelty Healthshine and is now investing his time helping it reach even greater success. He sees the company as a listed one in another 5 years and at par with leading pharma companies. Mr Raajesh, is a self-motivated person and as any motivated person, he has a knack of developing talent by giving freedom of expression and ideas. He is highly receptive for innovating ideas and strategies to grow business and has a very strong appetite for novel ways to work. He has an extremely competent & committed team at work which is continuously working on delivering novel patient centric solutions & yes, a healthier and happier lifestyle.

      Raakesh Dhuria

      Raakesh is a very enthusiastic and energetic person with a perseverant nature. No wonder then, that he is an excellent leader guiding the field force at Novelty towards surpassing their goals year after year. Raakesh is one of the founder promoter Directors of Novelty HealthShine and has been associated with it since its inception. With his 30+ years of experience in Pharmaceutical selling he has risen from the ranks of a Medical representative to being a Director currently. Beginning his career at Lupin Laboratories, Raakesh has moved on to CFL as a frontline manager, followed by Morepen Laboratories. He embarked on his entrepreneurial journey beginning with Kinedex Healthcare and now at Novelty HealthShine. He has wide experience in selling brands of various therapeutic categories and supervising and motivating field force across the country. Raakesh is a Science Graduate with Masters in Business Administration and is passionate about keeping himself up-to-date with the latest in the field of medical and pharmaceutical research.

      Abhijit Singh

      Abhijit Singh is a seasoned Pharma leader who has front led Brand building, Business transformation & turnaround initiatives. With more than 2 decades of experience majorly in leadership positions at Zydus & Torrent - he is associated with popular brands with extensive work in Gastroenterology therapeutic area. A product innovator and a strategic thinker, he is constantly in pursuit of excellence in marketing and bringing about innovation to the customers. As an Executive Director at Novelty health shine, he is nurturing a multi-therapy product line with a focus on Nutrition. His role here is to bring innovation and carve a strategic charter to help the brands scale rapidly. Abhijit holds a Bachelor’s degree in Biochemistry and a Masters in Business Administration.

      Download Brochure

      Kindly fill in your details. All fields mandatory.